Samsara BioCapital »

Abivax SA F shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.8M 850k 11.52
2024-06-30 $11M 850k 13.22
2024-03-31 $12M 850k 14.30
2023-12-31 $9.1M 850k 10.70

More positions owned by Samsara BioCapital

Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Scholar Rock Hldg Corp (SRRK)
Neurogene (NGNE)
Alumis Common Stock (ALMS)
Arcellx Common Stock (ACLX)
Lenz Therapeutics (LENZ)
Nkarta (NKTX)
Eliem Therapeutics (ELYM)
Avadel Pharmaceuticals Com Shs (AVDL)
Zymeworks Del (ZYME)
Acelyrin (SLRN)
Contineum Therapeutics Cl A (CTNM)
Jasper Therapeutics Com New (JSPR)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Abivax SA F

TCG Crossover Management
Deep Track Capital
Cormorant Asset Management
Dr. Jeffrey R. Jay, M.D.
Blackstone Group
VR Adviser
Franklin Resources
Commodore Capital
Henderson Group
Nantahala Capital Management
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Point72 Asset Management
Citadel Advisors

View all funds holding Abivax SA F